(Q42461940)

English

Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas

scientific article published on May 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Polymorphous low-grade adenocarcinoma

0 references

1 reference

based on heuristic

inferred from title

adenoid cystic carcinoma

1 reference

based on heuristic

inferred from title

Paul C. Edwards

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

author name string

Tawfiqul Bhuiya

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Robert D Kelsch

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2004

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

613-619

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Taking advantage of basic research: p63 is a reliable myoepithelial and stem cell marker

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

p63 and p73 are required for p53-dependent apoptosis in response to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

From p63 to p53 across p73.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

On the shoulders of giants: p63, p73 and the rise of p53.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

p63 is a p53 homologue required for limb and epidermal morphogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

p63 identifies keratinocyte stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

The p63 gene in EEC and other syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

P63 gene mutations and human developmental syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

Immunoreactivity of alpha smooth muscle actin in salivary gland tumours: a comparison with S100 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

Polymorphous low-grade adenocarcinoma of minor salivary gland. A comparative histologic and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

Characterization of the cellular component of polymorphous low-grade adenocarcinoma by immunohistochemistry and electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

Canalicular adenoma of the buccal mucosa. An ultrastructural and histochemical study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

Expression profiles of p53, p63, and p73 in benign salivary gland tumors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2003.09.010

7 January 2021

Identifiers

10.1016/J.TRIPLEO.2003.09.010

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42461940&oldid=1958473728"